Loading...
Market
Which Company Will First Adopt PacBio's SPRQ Chemistry for Large-Scale Sequencing by End of 2024?
2
Resolution / Starting Odds
Illumina • 25%
Thermo Fisher • 25%
Roche • 25%
Other • 25%
Official announcements from the companies or PacBio
Story
PacBio Unveils SPRQ Chemistry for Revio, Cutting Genome Sequencing Costs to $500
Oct 29, 2024, 04:41 PM
Pacific Biosciences (PacBio) has announced a significant advancement in its sequencing technology with the introduction of SPRQ chemistry for the Revio Sequencing Systems. This new long-read sequencing chemistry is expected to reduce the cost of sequencing a human genome to less than $500, which represents a 50% reduction in sequencing costs. The improvements are anticipated to increase the system's output and efficiency, marking a major milestone for the company and the genomics industry. This development is seen as an 'inflection point' for PacBio, potentially transforming the economics of genome sequencing. The announcement was made at ASHG24, and its impact on Kinnex will be discussed separately.
View original story
Similar markets
Illumina • 25%
Thermo Fisher Scientific • 25%
Bio-Rad Laboratories • 25%
Other • 25%
Illumina • 25%
Thermo Fisher Scientific • 25%
Pacific Biosciences • 25%
Other • 25%
Cancer Research • 25%
Neurological Disorders • 25%
Genetic Disorders • 25%
Other • 25%
A cancer diagnostics company • 25%
A gene sequencing company • 25%
A biotech company unrelated to cancer diagnostics • 25%
No major acquisition • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Yes • 50%
No • 50%
Wave Life Sciences • 25%
ProQR Therapeutics • 25%
Korro Bio • 25%
Other • 25%
Yes • 50%
No • 50%
PacBio sequencing • 25%
Nanopore sequencing • 25%
Illumina sequencing • 25%
Other • 25%
